Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Se Ik Kim

Showing results (81-90 of 138) with videos related to

Pageof 14
Sort By:
Journal of Gynecologic Oncology|March 29, 2024
Chemotherapy response score no longer predicts survival outcomes in high-grade serous ovarian cancer patients with <i>BRCA</i> mutation and/or maintenance therapyYoung Joo Lee, Yoon Kyung Shin, Nae Ry Kim, et al.
Nutrients|December 22, 2019
Decursin and Decursinol Angelate Suppress Adipogenesis through Activation of β-catenin Signaling Pathway in Human Visceral Adipose-Derived Stem CellsIn Sil Park, Boyun Kim, Youngjin Han, et al.
Molecular Carcinogenesis|March 15, 2021
Computational modeling of malignant ascites reveals CCL5-SDC4 interaction in the immune microenvironment of ovarian cancerSoochi Kim, Youngjin Han, Se Ik Kim, et al.
BMC Cancer|June 27, 2022
Clinical implications of neoadjuvant chemotherapy in advanced endometrial cancer: a multi-center retrospective cohort studyHyunji Lim, Seung Hyun Bang, Yeorae Kim, et al.
Journal of Gynecologic Oncology|March 8, 2023
Major clinical research advances in gynecologic cancer in 2022: highlight on late-line PARP inhibitor withdrawal in ovarian cancer, the impact of ARIEL-4, and SOLO-3Jung-Yun Lee, Yoo-Young Lee, Jeong-Yeol Park, et al.
Cancers|May 28, 2020
Metagenomic Analysis of Serum Microbe-Derived Extracellular Vesicles and Diagnostic Models to Differentiate Ovarian Cancer and Benign Ovarian TumorSe Ik Kim, Nayeon Kang, Sangseob Leem, et al.
Yonsei Medical Journal|July 13, 2016
Knowledge of HPV and Surgery among Women Who Underwent Cervical Conization: A Korean Multi-Center StudySo Yeun Jun, Se Ik Kim, Myong Cheol Lim, et al.
Cancer Research and Treatment|November 18, 2021
Identification of Patients with Recurrent Epithelial Ovarian Cancer Who Will Benefit from More Than Three Lines of ChemotherapyAeran Seol, Ga Won Yim, Joo Yeon Chung, et al.
Gynecologic Oncology|January 16, 2019
Comparison of survival outcomes between minimally invasive surgery and conventional open surgery for radical hysterectomy as primary treatment in patients with stage IB1-IIA2 cervical cancerSe Ik Kim, Jae Hyun Cho, Aeran Seol, et al.
BMC Cancer|May 3, 2018
LYL1 gene amplification predicts poor survival of patients with uterine corpus endometrial carcinoma: analysis of the Cancer genome atlas dataSe Ik Kim, Ji Won Lee, Nara Lee, et al.
Pageof 14

Showing results (81-90 of 138) with videos related to

Sort By:
Pageof 14
Journal of Gynecologic Oncology|March 29, 2024
Chemotherapy response score no longer predicts survival outcomes in high-grade serous ovarian cancer patients with <i>BRCA</i> mutation and/or maintenance therapyYoung Joo Lee, Yoon Kyung Shin, Nae Ry Kim, et al.
Nutrients|December 22, 2019
Decursin and Decursinol Angelate Suppress Adipogenesis through Activation of β-catenin Signaling Pathway in Human Visceral Adipose-Derived Stem CellsIn Sil Park, Boyun Kim, Youngjin Han, et al.
Molecular Carcinogenesis|March 15, 2021
Computational modeling of malignant ascites reveals CCL5-SDC4 interaction in the immune microenvironment of ovarian cancerSoochi Kim, Youngjin Han, Se Ik Kim, et al.
BMC Cancer|June 27, 2022
Clinical implications of neoadjuvant chemotherapy in advanced endometrial cancer: a multi-center retrospective cohort studyHyunji Lim, Seung Hyun Bang, Yeorae Kim, et al.
Journal of Gynecologic Oncology|March 8, 2023
Major clinical research advances in gynecologic cancer in 2022: highlight on late-line PARP inhibitor withdrawal in ovarian cancer, the impact of ARIEL-4, and SOLO-3Jung-Yun Lee, Yoo-Young Lee, Jeong-Yeol Park, et al.
Cancers|May 28, 2020
Metagenomic Analysis of Serum Microbe-Derived Extracellular Vesicles and Diagnostic Models to Differentiate Ovarian Cancer and Benign Ovarian TumorSe Ik Kim, Nayeon Kang, Sangseob Leem, et al.
Yonsei Medical Journal|July 13, 2016
Knowledge of HPV and Surgery among Women Who Underwent Cervical Conization: A Korean Multi-Center StudySo Yeun Jun, Se Ik Kim, Myong Cheol Lim, et al.
Cancer Research and Treatment|November 18, 2021
Identification of Patients with Recurrent Epithelial Ovarian Cancer Who Will Benefit from More Than Three Lines of ChemotherapyAeran Seol, Ga Won Yim, Joo Yeon Chung, et al.
Gynecologic Oncology|January 16, 2019
Comparison of survival outcomes between minimally invasive surgery and conventional open surgery for radical hysterectomy as primary treatment in patients with stage IB1-IIA2 cervical cancerSe Ik Kim, Jae Hyun Cho, Aeran Seol, et al.
BMC Cancer|May 3, 2018
LYL1 gene amplification predicts poor survival of patients with uterine corpus endometrial carcinoma: analysis of the Cancer genome atlas dataSe Ik Kim, Ji Won Lee, Nara Lee, et al.
Pageof 14